SAKK 16/14-Peripheral immune cell populations in response to neoadjuvant durvalumab in patients with stage IIIA(N2) NSCLC

D. Schmid, M. Trueb, P. Herzig, C. Gartner-Pelham, I. Alborelli, K. Leonards, M. Manzo, P. Jermann,S. Savic-Prince,E. Keller, S. Hayoz, S. Chiquet, M. Schneider, A. B. Sobottka-Brillout, M. Nowack, G. Tochtermann, V. H. Koelzer, D. Konig, M. Pless, A. Zippelius, S. I. Rothschild

JOURNAL OF THORACIC ONCOLOGY（2022）

引用 0|浏览1